VRTX
Vertex Pharmaceuticals Inc
Price:  
480.73 
USD
Volume:  
640,794.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Vertex WACC - Weighted Average Cost of Capital

The WACC of Vertex Pharmaceuticals Inc (VRTX) is 8.9%.

The Cost of Equity of Vertex Pharmaceuticals Inc (VRTX) is 8.95%.
The Cost of Debt of Vertex Pharmaceuticals Inc (VRTX) is 7.00%.

Range Selected
Cost of equity 7.70% - 10.20% 8.95%
Tax rate 15.10% - 16.30% 15.70%
Cost of debt 4.60% - 9.40% 7.00%
WACC 7.7% - 10.2% 8.9%
WACC

Vertex WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.83 0.95
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.70% 10.20%
Tax rate 15.10% 16.30%
Debt/Equity ratio 0 0
Cost of debt 4.60% 9.40%
After-tax WACC 7.7% 10.2%
Selected WACC 8.9%